NCT05123950View on ClinicalTrials.gov

A Study of Treatment Patterns and Clinical Outcomes in First Line Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck (1L R/M SCCHN) Participants in Europe

CompletedOBSERVATIONAL
Enrollment

304

Participants

Timeline

Start Date

January 1, 2019

Primary Completion Date

March 19, 2021

Study Completion Date

March 19, 2021

Conditions
Squamous Cell Carcinoma of the Head and Neck
Trial Locations (1)

07054

Medical Data Analytics, Parsippany

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY

NCT05123950 - A Study of Treatment Patterns and Clinical Outcomes in First Line Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck (1L R/M SCCHN) Participants in Europe | Biotech Hunter | Biotech Hunter